{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T09:08:59Z","timestamp":1740128939272,"version":"3.37.3"},"reference-count":21,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2024,9,3]],"date-time":"2024-09-03T00:00:00Z","timestamp":1725321600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/100000133","name":"Agency for Healthcare Research and Quality","doi-asserted-by":"publisher","award":["R01HS024277"],"award-info":[{"award-number":["R01HS024277"]}],"id":[{"id":"10.13039\/100000133","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,22]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>The 2019 American Thoracic Society\/Infectious Diseases Society of America (ATS\/IDSA) community-acquired pneumonia (CAP) guidelines recommend that clinicians prescribe empiric antibiotics for methicillin-resistant Staphylococcus aureus or Pseudomonas aeruginosa only if locally validated risk factors (or 2 generic risk factors if local validation is not feasible) are present.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>In this cross-sectional study that included adults hospitalized for CAP across 50 hospitals in the Premier Healthcare Database from 2010 to 2015, we sought to describe how the use of extended-spectrum antibiotics (ESAs) and the coverage for patients with CAP due to restraint organisms would change under the 2 approaches described in the 2019 ATS\/IDSA guidelines. The proportion of ESA use in patients with CAP and the proportion of ESA coverage among patients with infections resistant to recommended CAP therapy were measured.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>In the 50 hospitals, 19%\u201375% of patients received ESAs, and 42%\u2013100% of patients with resistant organisms received ESAs. The median number of risk factors identified per hospital was 9 (interquartile range, 6\u201312). Overall, treatment according to local risk factors reduced the number of patients receiving ESAs by 38.8 percentage points and by 47.5 percentage points when using generic risk factors. However, the effect varied by hospital. The use of generic risk factors always resulted in less ESA use and less coverage for resistant organisms. Using locally validated risk factors resulted in a similar outcome in all but 1 hospital.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>Future guidelines should explicitly define the optimal trade-off between adequate coverage for resistant organisms and ESA use.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/cid\/ciae448","type":"journal-article","created":{"date-parts":[[2024,9,4]],"date-time":"2024-09-04T10:48:47Z","timestamp":1725446927000},"page":"1277-1282","source":"Crossref","is-referenced-by-count":0,"title":["Potential Implications of Using Locally Validated Risk Factors for Drug-Resistant Pathogens in Patients With Community-Acquired Pneumonia in US Hospitals: A Cross-Sectional Study"],"prefix":"10.1093","volume":"79","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1627-9777","authenticated-orcid":false,"given":"Hamlet","family":"Gasoyan","sequence":"first","affiliation":[{"name":"Center for Value-Based Care Research, Department of Internal Medicine and Geriatrics, Primary Care Institute , Cleveland Clinic, Cleveland, Ohio ,","place":["USA"]},{"name":"Department of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University , Cleveland, Ohio ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhishek","family":"Deshpande","sequence":"additional","affiliation":[{"name":"Center for Value-Based Care Research, Department of Internal Medicine and Geriatrics, Primary Care Institute , Cleveland Clinic, Cleveland, Ohio ,","place":["USA"]},{"name":"Department of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University , Cleveland, Ohio ,","place":["USA"]},{"name":"Department of Infectious Disease, Respiratory Institute , Cleveland Clinic, Cleveland, Ohio ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0533-4603","authenticated-orcid":false,"given":"Peter B","family":"Imrey","sequence":"additional","affiliation":[{"name":"Department of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University , Cleveland, Ohio ,","place":["USA"]},{"name":"Department of Quantitative Health Sciences, Lerner Research Institute , Cleveland Clinic, Cleveland, Ohio ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ning","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Quantitative Health Sciences, Lerner Research Institute , Cleveland Clinic, Cleveland, Ohio ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin G","family":"Mittman","sequence":"additional","affiliation":[{"name":"Center for Value-Based Care Research, Department of Internal Medicine and Geriatrics, Primary Care Institute , Cleveland Clinic, Cleveland, Ohio ,","place":["USA"]},{"name":"Department of Population and Quantitative Health Sciences, Case Western Reserve University School of Medicine , Cleveland, Ohio ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2063-1876","authenticated-orcid":false,"given":"Michael B","family":"Rothberg","sequence":"additional","affiliation":[{"name":"Center for Value-Based Care Research, Department of Internal Medicine and Geriatrics, Primary Care Institute , Cleveland Clinic, Cleveland, Ohio ,","place":["USA"]},{"name":"Department of Medicine, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University , Cleveland, Ohio ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2024,9,3]]},"reference":[{"key":"2024112123521567200_ciae448-B1","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1136\/thoraxjnl-2013-203384","article-title":"Multidrug-resistant pathogens in hospitalised patients coming from the community with pneumonia: a European perspective: table 1","volume":"68","author":"Aliberti","year":"2013","journal-title":"Thorax"},{"key":"2024112123521567200_ciae448-B2","doi-asserted-by":"crossref","first-page":"5262","DOI":"10.1128\/AAC.02582-14","article-title":"Epidemiology and predictors of multidrug-resistant community-acquired and health care-associated pneumonia","volume":"58","author":"Gross","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"2024112123521567200_ciae448-B3","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1164\/rccm.201908-1581ST","article-title":"Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America","volume":"200","author":"Metlay","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"2024112123521567200_ciae448-B4","doi-asserted-by":"crossref","first-page":"894","DOI":"10.7326\/0003-4819-144-12-200606200-00006","article-title":"Quality of care for patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease","volume":"144","author":"Lindenauer","year":"2006","journal-title":"Ann Intern Med"},{"key":"2024112123521567200_ciae448-B5","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1001\/jama.2010.672","article-title":"Antibiotic therapy and treatment failure in patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease","volume":"303","author":"Rothberg","year":"2010","journal-title":"JAMA"},{"key":"2024112123521567200_ciae448-B6","first-page":"1","volume-title":"Premier healthcare database white paper: data that informs and performs","author":"Premier Incorporated","year":"2020"},{"key":"2024112123521567200_ciae448-B7","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1017\/ice.2022.229","article-title":"Derivation and validation of a risk assessment model for drug-resistant pathogens in hospitalized patients with community-acquired pneumonia","volume":"44","author":"Rothberg","year":"2023","journal-title":"Infect Control Hosp Epidemiol"},{"key":"2024112123521567200_ciae448-B8","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1164\/rccm.200405-644ST","article-title":"Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia","volume":"171","author":"American Thoracic Society","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"2024112123521567200_ciae448-B9","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/00005650-199801000-00004","article-title":"Comorbidity measures for use with administrative data","volume":"36","author":"Elixhauser","year":"1998","journal-title":"Med Care"},{"key":"2024112123521567200_ciae448-B10","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.chest.2016.03.042","article-title":"Community-acquired pneumonia due to multidrug- and non-multidrug-resistant Pseudomonas aeruginosa","volume":"150","author":"Cill\u00f3niz","year":"2016","journal-title":"Chest"},{"key":"2024112123521567200_ciae448-B11","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1001\/archinte.162.16.1849","article-title":"Community-acquired pneumonia due to gram-negative bacteria and Pseudomonas aeruginosa","volume":"162","author":"Arancibia","year":"2002","journal-title":"Arch Intern Med"},{"key":"2024112123521567200_ciae448-B12","doi-asserted-by":"crossref","first-page":"e0119528","DOI":"10.1371\/journal.pone.0119528","article-title":"Individualizing risk of multidrug-resistant pathogens in community-onset pneumonia","volume":"10","author":"Falcone","year":"2015","journal-title":"PLoS One"},{"key":"2024112123521567200_ciae448-B13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/4706150","article-title":"Liver cirrhosis and diabetes mellitus are risk factors for Staphylococcus aureus infection in patients with healthcare-associated or hospital-acquired pneumonia","volume":"2016","author":"Wu","year":"2016","journal-title":"Pulm Med"},{"key":"2024112123521567200_ciae448-B14","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s10096-017-3100-y","article-title":"Clinical predictors of methicillin-resistant Staphylococcus aureus in nosocomial and healthcare-associated pneumonia: a multicenter, matched case\u2013control study","volume":"37","author":"Torre-Cisneros","year":"2018","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"2024112123521567200_ciae448-B15","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.jfma.2015.03.009","article-title":"Selection of empirical antibiotics for health care-associated pneumonia via integration of pneumonia severity index and risk factors of drug-resistant pathogens","volume":"115","author":"Wang","year":"2016","journal-title":"J Formosan Med Assoc"},{"key":"2024112123521567200_ciae448-B16","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/cid\/ciz876","article-title":"Sputum gram stain for bacterial pathogen diagnosis in community-acquired pneumonia: a systematic review and Bayesian meta-analysis of diagnostic accuracy and yield","volume":"71","author":"Ogawa","year":"2020","journal-title":"Clin Infect Dis"},{"key":"2024112123521567200_ciae448-B17","doi-asserted-by":"crossref","first-page":"ofaa307","DOI":"10.1093\/ofid\/ofaa307","article-title":"Normal respiratory flora as a cause of community-acquired pneumonia","volume":"7","author":"Musher","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"2024112123521567200_ciae448-B18","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/S1473-3099(16)30267-5","article-title":"Global initiative for meticillin-resistant Staphylococcus aureus pneumonia (GLIMP): an international, observational cohort study","volume":"16","author":"Aliberti","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"2024112123521567200_ciae448-B19","doi-asserted-by":"crossref","first-page":"1701190","DOI":"10.1183\/13993003.01190-2017","article-title":"Burden and risk factors for Pseudomonas aeruginosa community-acquired pneumonia: a multinational point prevalence study of hospitalised patients","volume":"52","author":"Restrepo","year":"2018","journal-title":"Eur Respir J"},{"key":"2024112123521567200_ciae448-B20","doi-asserted-by":"crossref","first-page":"2652","DOI":"10.1128\/AAC.03071-15","article-title":"Derivation and multicenter validation of the drug resistance in pneumonia clinical prediction score","volume":"60","author":"Webb","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"2024112123521567200_ciae448-B21","first-page":"430","article-title":"Association between use of EHR-generated dashboards and hospital outcomes in 30-day heart failure readmissions","volume":"65","author":"Gasoyan","year":"2020","journal-title":"J Healthc Manag"}],"container-title":["Clinical Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cid\/advance-article-pdf\/doi\/10.1093\/cid\/ciae448\/59385595\/ciae448.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/79\/5\/1277\/60779297\/ciae448.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cid\/article-pdf\/79\/5\/1277\/60779297\/ciae448.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,21]],"date-time":"2024-11-21T23:53:21Z","timestamp":1732233201000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cid\/article\/79\/5\/1277\/7748372"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,3]]},"references-count":21,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,9,3]]},"published-print":{"date-parts":[[2024,11,22]]}},"URL":"https:\/\/doi.org\/10.1093\/cid\/ciae448","relation":{},"ISSN":["1058-4838","1537-6591"],"issn-type":[{"type":"print","value":"1058-4838"},{"type":"electronic","value":"1537-6591"}],"subject":[],"published-other":{"date-parts":[[2024,11,15]]},"published":{"date-parts":[[2024,9,3]]}}}